Elevated expression of granulysin is associated with favourable outcomes in various cancers [123,124,125]; however, in MF, the granulysin is proposed to be an alarmin molecule attracting immature dendritic cells [126] which may promote immune tolerance to the tumor [127,128,129]. Here, GNLY is linked to cancer.